Increased plasma levels of tissue factor pathway inhibitor-activated factor X complex in patients with disseminated intravascular coagulation

American Journal of Hematology

Volumn 65, Issue 3, 2000, Pages 210-214

  Okugawa, Yoshinaga ^a   Wada, Hideo ^a,c   Noda, Tomohiro ^a   Sakakura, Miho ^a   Nakasaki, Takahiro ^a   Watanabe, Rika ^a   Deguchi, Hiroshi ^a   Gabazza, Esteban C ^a   Mori, Yoshitaka ^b   Nishikawa, Masakatsu ^a   Deguchi, Katsumi ^a   Nobori, Tsutomu ^a   Shiku, Hiroshi ^a  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mie Red Cross Blood Center   (Japan)

^c MIE UNIVERSITY   (Japan)

Author keywords

DIC; Pre DIC; TF; TFPI; TFPI Xa complex

Indexed keywords

ANTIPLASMIN; BLOOD CLOTTING FACTOR 10A; D DIMER; FIBRIN MONOMER; FIBRINOGEN; PLASMIN; PROTEIN C; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR;

ARTICLE; BLOOD CLOTTING; BLOOD LEVEL; COMPLEX FORMATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISSEMINATED INTRAVASCULAR CLOTTING; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME;

ANTICOAGULANTS; DISSEMINATED INTRAVASCULAR COAGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FACTOR XA; FIBRINOLYTIC AGENTS; HUMAN; LIPOPROTEINS; SUPPORT, NON-U.S. GOV'T;

EID: 0033787858     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-8652(200011)65:3<210::AID-AJH6>3.0.CO;2-P     Document Type: Article

References (22)

1. Factor proteins in the assembly and expression of blood clotting enzyme complexes
2. Heparin and low molecular weight heparins inhibit prothrombinase formation but not its activity in plasma
3. Measurement of factor Xa-antithrombin III in plasma: Relationship to prothrombin activation in vivo
4. Role of membrane in the inactivation of factor Va by activated protein C
5. The extrinsic pathway inhibitor: A regulator of tissue-factor-dependent blood coagulation
6. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor
7. Kinetics of the inhibition of human factor Xa by full-length and truncated recombinant tissue factor pathway inhibitor
8. Tissue factor pathway inhibitor
9. Inhibition of factor VIIa/tissue factor-induced blood coagulation with particular emphasis upon a factor Xa-dependent inhibitory mechanism
10. Regulation of coagulation by a multivalent Kunitz-type inhibitor
11. Kinetics of the inhibition of tissue-factor-factor VIIa by tissue factor pathway inhibitor
12. Tissue factor pathway inhibitor and the current concept of blood coagulation
13. Functional and immunologic methods for the measurement of human tissue factor pathway inhibitor
14. Increased truncated form of plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation
15. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation
16. Criteria for diagnosis of DIC based on the analysis of clinical and laboratory findings in 345 DIC patients collected by the Research Committee on DIC in Japan
17. Hemostatic study before onset of disseminated intravascular coagulation
18. Quantitation of TFPI/Xa complexes with the IMUBIND® TFPI/Xa ELISA: A precise test for onset of thrombophilia
19. Increased plasma soluble fibrin monomer levels in patients with disseminated intravascular coagulation
20. Outcome of disseminated begun
21. Increased vascular endothelial cell markers in patients with disseminated intravascular coagulation
22. Plasma tissue factor pathway inhibitor levels in patients with disseminated intravascular coagulation